📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

5[beta]-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro (2019)

First Author: Nikolaou N

Attributed to: Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/endoabs.65.oc1.4

Publication URI: http://dx.doi.org/10.1530/endoabs.65.oc1.4

Type: Journal Article/Review

Parent Publication: Endocrine Abstracts